SEKISUI: Enhancement Of Medical Business In China

Date: 3 March 2010
Source: SEKISUI
The High Performance Plastics Company (President: Takayoshi Matsunaga) of SEKISUI CHEMICAL CO., LTD. (President: Naofumi Negishi, hereinafter Sekisui Chemical) has announced plans to merge two subsidiaries related to medical business in China, in order to enhance business in that market.  1.

Background
Until now, BEIJING SEKISUI TRANK MEDICAL TECHNOLOGY CO., LTD. (hereinafter Sekisui Trank) has handled business development in China in the area of vacuum blood collection tubes, and SHANGHAI DAIICHI DIAGNOSTICS, CO., LTD. (hereinafter Shanghai Daiichi) has handled business development in China in the area of clinical reagents.
 
Sekisui Trank, established as a joint venture with a Chinese firm, manufactures and sells vacuum blood collection tubes. In addition to its plant in Beijing, it also has sales facilities located across China, and it is achieving steady sales growth including exports to Asian markets.
 
Shanghai Daiichi provides support for the activities of sales agents in China for reagents exported by SEKISUI MEDICAL CO., LTD. (hereinafter Sekisui Medical). Against a background of a growing Chinese market for reagents, in recent years the value of exports has continued to increase from year to year.
 
2. Outline of this merger
With this merger, Shanghai Daiichi will be merged into Sekisui Trank, to form a major facility in the Chinese market. Plans call for the merger procedures to be completed in September of this year.
 
Also, plans call for the Sekisui Trank plant that currently produces vacuum blood collection tubes to begin production of clinical reagents as well following the merger.
 
Also, in advance of this merger Sekisui Chemical accepted transfer in December of last year of a 15% of equity stake held by a Chinese joint-venture partner of Sekisui Trank, increasing its stake in the company from 85% to 100%. Furthermore, in February of this year the name of Sekisui Trank was changed to SEKISUI MEDICAL TECHNOLOGY (CHINA) LTD., to develop a unified brand image and increase its presence in the medical industry in China.
 
Read more here.

600450 SEKISUI: Enhancement Of Medical Business In China glassonweb.com
Date: 3 March 2010
Source: SEKISUI

See more news about:

See more from these topics:

Others also read

Kohn Pedersen Fox (KPF) proudly supported the opening of MGM COTAI on Tuesday, February 13 2018. The resort is the latest addition to the MGM portfolio in Macau.
With various features including light weight, thin thickness, clear transparency, high safety, and extensive use in many aspects of building construction without regional limitation, LandVac has been well received by consumers.
As the launch pad for new products and technologies on window, door and facade in China, the 24th Windoor Expo will take place in Guangzhou from March 11 to March 13, 2018.
Considering the use of energy-saving glass as the determinant of a building’s power conservation, vacuum insulated glass currently offers the most outstanding performance in energy-saving. Among them, LandVac® is one of the best.
Recently, LandGlass is successfully selected into the list of the Innovative Large Enterprises of the City by the department of science and technology in Luoyang.
Glass expertise in oversize formats.

From industry

No. 160 Yichuan Rd.,
Jiaonan Shi
Qingdao Shi
Shandong Sheng, 266000
China

Add new comment